Stronger Sell Today APTO ranks #3426 as SELL CANDIDATE #3426 Weaker Sell

APTO stock forecast Aptose Biosciences

APTO stock forecast

Monday October 14, 2019 Change 0.00% Price $2.00
Your prediction: Prediction: Request




APTO Forecast and Technical Stock Analysis

Sell candidate since 2019-09-20 Loss -15.25% PDF

No changes to the price of Aptose Biosciences in the last trading day ( Monday, 14th Oct 2019 ). During the day the stock fluctuated 7.69% from a day low at $1.95 to a day high of $2.10. The price has fallen in 6 of the last 10 days and is down by -4.08% for this period.

Quick summary:

  • 30 day high of the APTO stock price was $2.59 and low was $1.89.
  • 90 day high was $3.13 and low was $1.89.
  • 52 week high for Aptose Biosciences - $3.13 and low - $1.57.
Top Trending Stocks


Aptose Biosciences lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.50% during the next 3 months and, with 90% probability hold a price between $1.43 and $1.94 at the end of this period.

Top Golden Star Stocks


A buy signal was issued from a pivot bottom point on Friday October 11, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Aptose Biosciences holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.05 and $2.30. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 39 and the stock is currently not being overbought or oversold

* uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

Aptose Biosciences finds support from accumulated volume at $1.92.

Support: $1.92 Price: $2.00 Resistance: $2.05


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.15 between high and low, or 7.69%. For the last week the stock has had a daily average volatility of 8.81%.

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

8.81 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Sell Candidate Upgraded


Aptose Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Stronger Sell Today APTO ranks #3426 as SELL CANDIDATE #3426 Weaker Sell
Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSX | BRU

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
Trading With Moving Average
As an investor, you always seek to understand what other... Full Article
Pivot Points
Pivot Points refer to points of significant change. As a... Full Article
Accumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full Article
Volume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full Article
We Give Back!
In 2016 donated to NGO Goodwill projects to help purchase medical... Full Article
Better Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full Article

Proudly made at